Nautilus Biotechnology (NAUT) Prepaid Assets (2020 - 2026)
Nautilus Biotechnology's (NAUT) quarterly Prepaid Assets came in at $3.0 million in Q1 2026, up 6.16% year-on-year from $2.8 million in Q1 2025, and up 15.88% quarter-over-quarter from $2.6 million in Q4 2025.
Nautilus Biotechnology (NAUT) Prepaid Assets (2020 - 2026) Analysis & Trends
Nautilus Biotechnology has disclosed Prepaid Assets across 7 years of filings, most recently posting $3.0 million for Q1 2026.
- Prepaid Assets for Q1 2026 came in at $3.0 million, up 6.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.0 million (up 6.16% YoY), and the FY2025 annual result was $2.6 million, down 12.82% from the prior year.
- Prepaid Assets came in at $3.0 million for Q1 2026 at Nautilus Biotechnology, up from $2.6 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $4.1 million in Q2 2022 to a low of $2.6 million in Q4 2025.
- The 5-year median for Prepaid Assets is $3.1 million (2023), against an average of $3.2 million.
- Peak annual rise in Prepaid Assets reached 1062.32% in 2022, while the deepest fall reached 33.28% in 2022.
- Nautilus Biotechnology's Prepaid Assets stood at $2.7 million in 2022, then grew by 24.87% to $3.4 million in 2023, then retreated by 14.21% to $2.9 million in 2024, then dropped by 12.82% to $2.6 million in 2025, then increased by 15.88% to $3.0 million in 2026.
- The last three Prepaid Assets figures came in at $3.0 million (Q1 2026), $2.6 million (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Nautilus Biotechnology | 289.99 Mn | 194.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.96 Mn |
| Dec 31, 2025 | 2.56 Mn |
| Sep 30, 2025 | 2.90 Mn |
| Jun 30, 2025 | 2.85 Mn |
| Mar 31, 2025 | 2.79 Mn |
| Dec 31, 2024 | 2.93 Mn |
| Sep 30, 2024 | 3.60 Mn |
| Jun 30, 2024 | 3.49 Mn |
| Mar 31, 2024 | 3.73 Mn |
| Dec 31, 2023 | 3.42 Mn |
| Sep 30, 2023 | 3.50 Mn |
| Jun 30, 2023 | 3.41 Mn |
| Mar 31, 2023 | 3.14 Mn |
| Dec 31, 2022 | 2.74 Mn |
| Sep 30, 2022 | 3.25 Mn |
| Jun 30, 2022 | 4.11 Mn |
| Mar 31, 2022 | 2.95 Mn |
| Dec 31, 2021 | 3.49 Mn |
| Sep 30, 2021 | 4.88 Mn |
| Jun 30, 2021 | 1.48 Mn |